PepperLime Health Acquisition - Warrants (01/10/2026) Return on Equity

PepperLime Health Acquisition - Warrants (01/10/2026)'s return on equity stands at 91.4%. That is above the sector sector average of 11.85%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

PepperLime Health Acquisition - Warrants (01/10/2026) sits higher the its sector benchmark (11.85%) with a ROE of 91.4%. That is roughly 671.1% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A ROE of 91.4% for PepperLime Health Acquisition - Warrants (01/10/2026) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how PepperLime Health Acquisition - Warrants (01/10/2026)'s ROE evolved across reporting periods, while the comparison chart places PEPLW next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.